Rituximab in Lymphoma and Chronic Lymphocytic Leukemia: A Clinical Practice Guideline, Version 3 savita thakur thakur31 March 2015 3:19 PM ISTA Clinical Practice Guideline int he use of Rituximab in Lymphoma and Chronic Lymphocytic Leukemia were issued 31 March 2015 by Cancer Care Ontario...
Thyrotoxicosis- Standard Treatment Guidelines supriya kashyap kashyap20 April 2017 9:16 AM ISTMinistry of Health and Family Welfare, Government of India has issued the Standard Treatment Guidelines for Thyrotoxicosis.Following are the major...
Rituxan major advancement in the treatment of Severe Pemphigus Vulgaris Vinay Singh singh13 Jun 2018 7:25 PM ISTRituxan (rituximab; Genentech and Biogen) was approved by the Food and Drug Administration (FDA) for the treatment of adults with moderate to severe...
Latest DMARD safety guidelines in inflammatory arthritis by BSR Vinay Singh singh10 Sept 2018 7:03 PM ISTThe British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis aims to provide evidence-based recommendations, which...
An Unusual Presentation of Wegner’s granulomatosis Medha Baranwal Baranwal19 Sept 2018 6:00 PM ISTDr Sunil Pokharel and colleagues have reported a case of Granulomatosis with Polyangiitis (GPA) {formerly known as Wegner’s granulomatosis}. The case...
A case of brown and striped nails after chemotherapy Hina Zahid22 Oct 2018 6:00 PM ISTDr Musa F. Alzahrani at King Saud University, Riyadh, Saudi Arabia has reported a case of nails turning brown and striped after chemotherapy. The case...
Rheumatoid Arthritis Complicated by Myositis and Vasculitic Neuropathy: A rare link Deepanjana Sarkar10 Jun 2019 6:00 PM ISTThe case of 36-year-old rheumatoid arthritis (RA) patient who was diagnosed with myositis and vasculitic neuropathy was published in the Journal of...
FDA approves first treatment for rare vasculitis in children Dr. Kamal Kant Kohli Kohli28 Sept 2019 5:31 AM ISTFood and Drug Administration has approved first treatment for rare vasculitis in children.The U.S. Food and Drug Administration today approved...
